• Explore /
  • Poster
  • / TRIBE-2 by GONO group: A phase III strategy study in the first- and second-line treatment of unresectable metastatic colorectal cancer (mCRC) patients.

TRIBE-2 by GONO group: A phase III strategy study in the first- and second-line treatment of unresectable metastatic colorectal cancer (mCRC) patients.

Abstract Poster

Authors

null

Chiara Cremolini

Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy

Chiara Cremolini , Fotios Loupakis , Luca Boni , Sara Lonardi , Vittorina Zagonel , Elena Ongaro , Gianluca Masi , Emiliano Tamburini , Cristina Granetto , Monica Ronzoni , Lisa Salvatore , Filippo Pietrantonio , Giacomo Allegrini , Samantha Di Donato , Gianluca Tomasello , Daniele Santini , Stefano Sergio Cordio , Domenico C. Corsi , Giuseppe Fornarini , Alfredo Falcone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT02339116

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS3629)

DOI

10.1200/JCO.2016.34.15_suppl.TPS3629

Abstract #

TPS3629

Poster Bd #

323b

Abstract Disclosures

Similar Posters

First Author: Yuki Matsubara

First Author: Kentaro Yamazaki

First Author: Benoist Chibaudel

Poster

2014 Gastrointestinal Cancers Symposium

Cost differential among systemic therapies for colon cancer.

Cost differential among systemic therapies for colon cancer.

First Author: Hasan Nadeem